.png){kind=icon}
.png){kind=icon}
Return
A statewide multi-institutional model that de-risks academic drug discovery
.png){kind=icon}
PRE
AI
S
DOI：10.1016/j.drudis.2026.104685.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
• Collaborative-core network cuts redundancy and raises rigor in drug R&D. • State public funding (CPRIT) builds industry-grade capacity. • Proven impact: 750+ projects, 60+ startups, 15 in clinic, >US$586M follow-on funding. • Shared, cross-core training builds a ready biotech workforce; Texas is drawing increasing attention from investors and industry.
Keywords:
drug discovery
collaborative-core network
public funding
biotech workforce
academic-industry collaboration
Journal
IF:
7.5
Papers:
6.3K
Citations:
2.3W
Organization
Cited Papers